Orthopedic devices—especially for sports medicine and fixation—are driving molding toward tighter tolerances, smaller geometries, and more integrated functionality. “We’re seeing greater demand for these injection molded parts—like anchors, fasteners, and instrument components—to replace multi-piece assemblies,” said Lindsay Mann, director of sales and marketing for MTD Micro Molding, a Charlton, Mass.-based provider of micro injection molding for the medical and health-tech markets.

“Also, for advanced surgical and implant systems, molding directly influences mechanical performance, dimensional stability, regulatory risk, and time to commercialization,” added Rob Morin, vice president of sales and marketing for PDC, a Scottsdale, Ariz.-based contract manufacturer specializing in precision micro injection molding and value-added assembly. “Orthopedic devices are becoming smaller, more integrated, and more materially demanding. As tolerances tighten and geometries shrink, molding must deliver more than dimensional compliance. It must deliver predictable, measurable behavior under load, sterilization, and validated production conditions.”

The medical device industry is shifting toward miniaturization wherever it can, with devices becoming smaller and more complex. “Closed-loop process control with real-time cavity pressure/temperature feedback and machine vision and in-line automated inspection inside cleanrooms ensure zero-defect output,” said Scott Herbert, president of RapidWerks, a Pleasanton, Calif.-based provider of precision micro molding to multiple markets, including the medical device industry. “Artificial intelligence [AI] and predictive analytics for predictive maintenance and optimization of molding parameters reduce cycle time variability and improves quality and traceability—a key regulatory requirement.”

Medical device manufacturers (MDMs) are intent on finding regenerative and integrative solutions that support healing at the bone-soft tissue interface. Bioabsorbables and high-performance polymers are expanding what can be accomplished through less-invasive procedures, with better precision and repeatability. In particular, bioabsorbables continue to mature in anchor, screw, staple, and drug delivery designs.

“Medical device designers are interested in materials that can compete with metals, such as these absorbable and bio-integrative options,” said Chris Thatcher, president and CEO of Tyngsborough, Mass.-based TESco Associates, a provider of proprietary polymer processing techniques for injection molding, extrusion, and specialty material blending. 

There is also a continuous need for high‑precision tooling and the capability to mold parts at extremely small shot sizes, while still maintaining material integrity. When critical dimensions and material behavior are tightly linked, design decisions made upfront directly impact validation timelines. This is where design for manufacturability (DFM) and early collaboration especially come into play. “As injection molding fundamentals remain stable, the focus becomes improving efficiency, repeatability, and miniaturization,” said Thatcher.

“We are definitely seeing more of these performance-driven micro features—micro ribs, feather edges, small holes, sharp tips—designed directly into the part,” said Mann. “This shifts the burden to tooling and process control to ensure those features are consistently achieved in validated production.”

In summary, micro molding is fast-becoming the standard for next-generation medical parts, requiring micron-level tolerances and exceptional surface finish—”critical for minimally invasive, microfluidic, and implantable devices,” said Herbert. “As an example, some advanced machines now reliably mold microscopic features such as channels and lattices used in lab-on-chip or micro-gear components.”

What MDMs Want

MDMs are actively looking to streamline and simplify their supply chains through strategic partnerships, not only to mitigate risk but to improve project lead times. Tighter tolerances and faster turnarounds, supported by traceable and repeatable measurement, are in high demand. Consistent production with micron-level precision, capabilities for microstructures such as tiny gears, vent features, seals, and fluidic channels, and repeatability over long runs without drift in dimensions are essential for minimally invasive surgical instruments, microfluidic cartridges, and implant components.

There is high demand for turnkey solutions that integrate prototyping, molding, packaging, and sterilization, all under one supplier. This includes small-batch capabilities, seamless transition to high-volume production, and options for quick mold revisions. Such flexibility is crucial for early clinical trials and design iterations.

“Customers increasingly value suppliers that can support regulatory pathways, especially amid updates to standards such as ISO 10993,” said Thatcher. “This is something we have seen sharply increase, which has driven the growth of our quality assurance and regulatory affairs team internally to support these types of inquiries.” 

MDMs are designing more products that require cleanroom standards and regulatory-ready manufacturing. Medical molding must often be performed in ISO Class 7 or 8 cleanrooms and provide robust documentation, including traceability to resin lot, cycle data, and operator identification. Compliance with ISO 13485 quality systems and rigorous validation protocols is also a must, ensuring devices meet regulatory expectations around contamination control and audit readiness.

This includes traceability and quality systems. “MDMs expect full traceability of parts and materials, integrated process data capture, and capability to support production part approval process validation and documentation,” said Herbert. “Automated data logging tied to quality records is now a standard evaluation criterion.”

Ultimately, orthopedic device designers want partners that provide engineering support and DFM feedback. This includes early DFM reviews, optimization of part geometry for micro molding feasibility, and alternative solutions to minimize cycle time and defects. This type of proactive collaboration reduces development cycles and manufacturing risk.

Current Molding Trends

Increasingly, MDMs are creating designs that require ultra-fine precision, simulation, and miniaturization. In turn, molders develop hybrid toolmaking methods that combine micro electrical discharge machining (EDM), femtosecond laser texturing, and precision hard-milling to deliver sharper edges and burr-free micro features. Together, these innovations enable cleaner knit lines, more reliable ultra-thin walls, and consistent lumen geometries. 

“Virtual replicas of micro-molding processes [digital twins, for example] enable the simulation and manipulation of process variations, optimization of cycle parameters before physical trials, and reduction of costly setup iterations,” said Herbert. “This speeds up qualification and lowers risk in tight-tolerance manufacturing.”

Toolmaking and mold technology are evolving rapidly:

• Conformal cooling improves cooling uniformity and part quality while reducing cycle times
• Computer numerical control (CNC) and EDM tooling enable ultra-precise cavities for sub-gram shot sizes
• 3D-printed micro tooling that supports rapid prototyping and complex geometries

“These tooling advances help achieve features that were previously impossible with conventional molds,” said Herbert.

With parts so small, traditional inspection is often insufficient. “Metrology has moved to the front of development,” said Mann. “For micro components, fast, traceable measurement is often the gating factor to move a program forward with data-driven confidence.”

Non-contact vision systems and computed tomography (CT) scanning are now standard for validating micro features. CT remains essential for internal features and overmolded interfaces. It provides sub-micron-level insights and saves considerable time compared to multi-set-up conventional inspections.

Advanced optical 3D technologies provide high-speed, non-contact, sub-micron precision measurement for complex surfaces. By utilizing technologies such as structured blue light, interferometry, and fringe projection, these systems deliver dense data for analytics and quality control. For example, a five-axis optical metrology system is capable of ultra-precise surface-level measurements, including both shape and surface roughness analysis. This advanced system enables comprehensive measurement planning, simulation, and automated execution, eliminating the need for deep metrology expertise or even the need for physical part availability in the early stages.

“We recently added optical 3D metrology to complement our CT scanning,” said Mann. “This has allowed faster, fully traceable measurement and gives us the ability to scan steel mold components to evaluate stack-ups and surface finishes before production risk shows up in parts. It turns what used to take hours or days into a 10-minute or less push-button process.” 

And, when integrated directly with statistical process control, “metrology can support FDA/ISO quality requirements, such as electronic device history record and ISO 13485 standards,” added Herbert.

Material Science Matters

Material expertise and processing support are key factors in achieving repeatable, high-precision micro molding. Material knowledge can dramatically influence functionality, sterilization resilience, and device performance. Therefore, MDMs want to work with molders that can recommend optimal, biocompatible materials, process challenging polymers such as polyether ether ketone (PEEK), liquid crystal polymer, and medical liquid silicone rubber, and handle multi-material designs and micro overmolding.

Advanced materials such as bioresorbables, antimicrobial additives, and nanomaterials are enhancing orthopedic device performance and safety. The increasing adoption of implantable-grade polymers, especially PEEK, has raised the technical demands placed on orthopedic molders. For example, implantable-grade PEEK introduces:

• Melt temperatures approaching 400°C
• Elevated mold temperature requirements
• Semi-crystalline shrink behavior
• Sensitivity to moisture and residence time
• Strict material traceability requirements

“Unlike amorphous polymers, semi-crystalline materials must crystallize during cooling,” said Morin. “That crystallization directly affects shrink rate, dimensional outcome, and mechanical properties. At micro scales, these effects are amplified.”

Bioabsorbable polymers such as polylactic acid and polyglycolic acid are popular materials for temporary implants and drug delivery. These materials are also being used in hybrid fixation devices, where a bioabsorbable part and a PEEK part are used in combination. Materials are also being specifically developed for sterilization, biocompatibility, and micro-feature retention. Multi-material co-molding/overmolding methods can combine rigid and elastomeric elements in a single part to create unique properties—for example, multiple durometers in a single component. 

How Small Is Small? 

Micro molding in orthopedics is defined by functional features operating near the limits of tooling and material physics.

PDC manufactures orthopedic-related components approximately 5 mm × 2.5 mm in implantable-grade PEEK. These parts incorporate precision through-holes measuring 0.018 inches (457 microns) in diameter. Critical features are controlled to ±2.5 micrometers, roughly half a percent of feature size.

“When your tolerance band is measured in single-digit microns on a 0.018-inch feature in implantable-grade PEEK, molding stops being a forming process and becomes an exercise in applied polymer physics,” said Morin. At this scale:

• Core pin rigidity becomes a primary constraint
• Tool steel wear directly influences drift
• Thermal symmetry governs crystallization consistency
• Packing profile determines shrink uniformity
• Moisture control affects viscosity and fill stability
• Measurement capability becomes limiting

“Anyone can produce one acceptable part,” he added. “The engineering challenge is producing thousands that are statistically indistinguishable. At the micro scale, repeatability, not peak capability, is the real differentiator.”

“The term ‘micro’ is typically defined by the critical features, not the overall part size,” added Mann. “Larger components with micro features can be more challenging to mold than small, simple geometry parts because of tolerance stack-up and geometry interaction.”

Micro design capabilities at MTD Micro Molding include:

• Wall stock in the 0.002-inch to 0.004-inch range
• Hole diameters around 0.002 inches
• Radii down to 0.0002 inches (5 µm)
• Production tolerances commonly held at 0.001 to 0.002 inches

Molding results depend on material characteristics such as viscosity, filler content, thermal sensitivity, and heat history. “For example,” continued Mann, “filled materials often force tighter control on temperature, venting, residence time, and gating strategy, while bioresorbables add constraints around degradation and post-mold property retention.”

“Ultimately, the relevant question becomes, ‘Can the product be molded, measured, validated, and scaled, with statistical stability?’” stated Morin.

Advanced Molding Processes

Using the latest high-precision molding techniques results in greater transparency and process control. Being able to micro mold is a competitive advantage for molders—not just for its incredible precision, but also for clearly documenting the manufacturing process for regulators and stakeholders. 

Precision at the micron level requires visibility inside the mold. Accomplishing this requires:

• Cavity pressure monitoring
• Mold surface temperature sensing
• Closed-loop packing control
• Automated handling systems
• Inline high-resolution vision inspection
• Serialized traceability

Cavity pressure monitoring is especially valuable in semi-crystalline materials. Minor thermal variations can alter crystallization behavior and dimensional outcome. “Real-time data allows detection of drift before dimensional trends exceed statistical limits,” said Morin. “AI is beginning to support anomaly detection by analyzing pressure curves and cycle signatures. It does not replace engineering judgment, but it strengthens predictive stability.”

Orthopedic systems often require integration between metal and polymer components. Insert molding enables insulation, retention features, alignment interfaces, and ergonomic structures. Successful integration requires differential thermal expansion, insert pre-heat temperature, resin flow relative to mechanical interlocks, and residual stress distribution.

“Improperly engineered insert molding introduces latent reliability risk,” said Morin. “Properly engineered integration reduces assembly steps and improves functional consistency. As device architectures become more integrated, molding strategy increasingly defines system architecture.”

Mann indicated the “biggest wins” come from integrating molding and secondary operations so that MDMs reduce parts, touches, and assembly components. For example:

• Overmolding/insert molding to build function into a single molded component 
• Overmolding onto delicate substrates where alignment and interfaces are critical to function
• Single-source micro manufacturing (tooling, molding, metrology, validation) to reduce iteration cycles and compress the path from prototype to validated production

Micro molding is advancing at the pace of orthopedic innovation. Devices are getting smaller, procedures are becoming less invasive, and interfaces demand greater precision. “Keeping up requires disciplined DFM, high-precision tooling, and metrology that can validate features at the micro scale,” said Mann.

For specialized orthopedic applications, MDMs are especially keen on micro molding because this process can eliminate secondary operations or produce geometry that would be difficult or uneconomical to machine at production volumes.

Raghu Vadlamudi, chief research and technology director at Donatelle, a DuPont Business that provides contract manufacturing services to the medical device industry, agreed.

“Micro molding is becoming a core manufacturing approach for parts that conventional molding cannot reliably make, and that trend will continue in the future,” he said. “Nano molding is on the horizon and exists more as research and/or a technical concept today rather than a traditional manufacturing method, though its principles indicate future material innovations.”

Nano molding technology (NMT) is a hybrid process that chemically and mechanically bonds thermoplastics to treated metal surfaces. “NMT achieves micro- and nano-scale adhesion by allowing plastic to flow into pre-treated nano-cavities on the metal surface during injection,” stated Plastics Engineering Magazine. “This results in a tight, durable bond that eliminates the need for glues or mechanical fasteners, simplifies manufacturing, and enhances product aesthetics. NMT creates mechanically interlocked interfaces between plastic and metal, delivering bonding strength significantly higher than insert molding.”¹

With NMT, manufacturers eliminate secondary operations such as adhesive application or overmolding, thus reducing production time and cost. The result is a cleaner, faster, and more scalable workflow compared with CNC machining or die casting.

Technology at the Forefront

Recent advances in orthopedic molding are characterized by a shift toward extreme precision, patient-specific customization, and the integration of smart technologies. However, micro molding can present challenges because device performance often depends on micron-scale features that are difficult to measure, control, and validate. If a part cannot be measured successfully, it cannot be verified. Therefore, it is crucial that validation rigor and traceability be built into the DFM process as early as possible.

“Regulatory challenges include demonstrating robust process validation within very tight process windows, proving measurement system capability at micron level tolerances, and establishing feature-level process capability,” said Vadlamudi. “Overall, micro molding success in orthopedic devices requires strong metrology and data-driven process control to satisfy FDA expectations.”

More molding advances are on the horizon. For example, integrating high-resolution, faster metrology directly into development and production loops will continue to shorten timelines. New prototyping approaches with robust tooling can reduce late-stage design iteration.

Other breakthroughs will be related to materials. Processing sensitive materials, especially bioabsorbables, is another molding challenge. Determining the best bioabsorbable material for an implant involves evaluating different degradation rates. Success also depends on specialized equipment, controlled handling, and real-time property verification. 

Although material additives and fillers can enable strength, stiffness, radiopacity, or wear properties, they can also impact tool wear, flow, and inspection strategy. “The tool, process, and metrology strategy must all be aligned from the outset,” said Mann.

The Internet of Things (IoT) will revolutionize the molding industry by improving flexibility and customization and shortening development times. Two of the top IoT technologies—AI and miniaturization—will continue to challenge (and transform) molding. 

Miniaturization in orthopedics is pushing measurement and verification to evolve as quickly as molding does. The ability to generate faster, high-resolution measurement data and use that data to refine tooling and processes early reduces risk and shortens development cycles.

AI and machine learning optimize parameters, reduce waste, and improve yields by detecting trends and defects early. AI can be used to identify new molding techniques for sensitive materials such as bioabsorbables. AI can be used to rapidly evaluate thousands of potential alloy combinations to find the one that is best for a particular project or product. AI is also advancing robot capabilities and is being integrated into inline vision and camera systems on molding and micro molding equipment. 

Moving Forward

Medical micro molding has become a go-to manufacturing process for complex, high-precision medical devices. Advances in automation, digitalization, materials, and tooling are driving tighter tolerances, faster qualifications, and improved quality—all while meeting stringent regulatory demands. MDMs are eager to integrate multiple technologies, including additive manufacturing, molding, and assembly, to reduce lead times and provide customized solutions, such as patient-specific devices. Electronics are being developed that can be inserted into very small, molded products for connectivity, remote monitoring, and diagnostic applications.

In summary, orthopedic systems are becoming more ambitious. Materials are stronger. Geometries are smaller. Tolerances are tighter. Precision at the micron level in implantable-grade polymers is achievable, but only through disciplined systems engineering. “When a 0.018-inch feature in semi-crystalline PEEK must be controlled to ±2.5 micrometers, success depends on tooling precision, thermal symmetry, process monitoring, and validated inspection,” said Morin. “The future of orthopedic molding will not be defined by who can produce the smallest feature once—it will be defined by who can produce it predictably, measurably, and repeatedly at scale.”

Reference
¹ tinyurl.com/mpo260301

---

Mark Crawford is a full-time freelance business and marketing/communications writer based in Corrales, N.M. His clients range from startups to global manufacturing leaders. He has written for MPO and ODT magazines for more than 15 years and is the author of five books.